AptarGroup, Inc. (NYSE:ATR) Q4 2025 Earnings Call Transcript February 6, 2026 Operator: Ladies and gentlemen, thank you for ...
The TrumpRx.gov website helps uninsured & cash-paying patients save on 40+ brand drugs. Here's the complete list of ...
Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.
Do Pfizer’s monthly GLP-1 data justify Metsera’s $10B price tag?; Trump administration pressed on details of its recent drug price deals; Measles cases identified at ICE’s largest detention facility ...
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of ...
The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...
Tanabe Pharma America’s small molecule designed to boost melanin production has hit the main goal of a phase 3 trial for patients with rare hereditary disorders that cause extreme sensitivity to ...
Jan 15 (Reuters) - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across ...
The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
2026 D Awards is back for its second celebration! On December 1, it was announced that the awards ceremony will take place on February 11, 2026, at Hwajeong Gymnasium of Korea University in Seoul. The ...
Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung cancer (NSCLC), results that can give the red-hot PD-(L)1xVEGF bispecific ...
Fintel reports that on October 29, 2025, D. Boral Capital maintained coverage of Medicus Pharma (NasdaqCM:MDCX) with a Buy recommendation. As of October 29, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results